Abstract
Preliminary reports suggest that during COVID-19, adolescents’ mental health has worsened while technology and social media use has increased. Much data derives from early in the pandemic, when schools were uniformly remote and personal/family stressors related to the pandemic were limited. This cross-sectional study, conducted during Fall 2020, examines the correlation between mental wellbeing and COVID-19-related changes in technology use, along with influence of COVID-19-related stressors, school status (in-person versus remote), and social media use for coping purposes, among 978 U.S. adolescents. Results suggest self-reported daily social media and technology use increased significantly from prior to COVID-19 through Fall 2020. Increased social media use was significantly associated with higher levels of anxiety and depressive symptoms regardless of other theoretical moderators or confounders of mental health (e.g., demographics, school status, importance of technology, COVID-19-related stress). Despite literature suggesting that remote learning may result in adverse mental health outcomes, we did not find local school reopening to be associated with current depressive/anxiety symptoms, nor with COVID-19-related increases in technology use. Self-reported use of social media for coping purposes moderated the association between increased social media use and mental health symptoms; in other words, some social media use may have positive effects. Although much prior research has focused on social media use as a marker of stress, we also found that increased video gaming and TV/movie watching were also associated with internalizing symptoms, in accordance with others' work. Future research should explore in more granular detail what, if any, social media and technology use is protective during a pandemic, and for whom, to help tailor prevention efforts.
Competing Interest Statement
Dr. Ranney holds stock in Moderna and has received money for consultation from Medscape for talks on COVID-19 testing. Drs. Ranney, Dunsiger, and Nugent have NIH and CDC grants for other projects.
Funding Statement
This study was funded by a grant from the Technology and Adolescent Mental Wellness (TAM) program at the University of Wisconsin-Madison, grant 0000000136/132580194.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Rhode Island Hospital IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of Interest Disclosures: Dr. Ranney holds stock in Moderna and has received money for consultation from Medscape for talks on COVID-19 testing. Drs. Ranney, Dunsiger, and Nugent have NIH and CDC grants for other projects.
Funding/Support: This study was funded by a grant from the Technology and Adolescent Mental Wellness (TAM) program at the University of Wisconsin-Madison, grant 0000000136/132580194.
Role of Funder/Sponsor: The Technology and Adolescent Mental Wellness (TAM) program had no role in the design and conduct of the study.
Abbreviations: none
Data Availability
Data may be made available upon request.